Category: Market Access

Pharmaceutical executives are navigating through an increasingly complex regulatory landscape due to the Inflation Reduction Act (IRA).  It introduced substantial drug cost shifting and now impacts strategic and analytical planning for insurance carriers and drug manufacturers alike. This pivotal legislation brings transparency, and Medicare negotiation to drug pricing, through measures like the 2024 Catastrophic Coverage […]

ARLINGTON – CareSet released the updated DocGraph HOP Teaming Dataset during the 2022 Health Datapalooza and National Health Policy Conference. The release offers the most detailed and up-to-date picture of patient-sharing relationships between all Medicare providers in the US healthcare system. This public use file provides some of the most timely and necessary insights into […]

Picture the following scenario: A patient presents with symptoms including numbness, tremors, and occasional weakness, among others. Genetic testing exists to check for rare cardiovascular diseases and defects, but it is expensive and not currently listed as part of the diagnosis protocol. Because of this, his doctors didn’t order the test. He suffered from these […]

Navigating the world of Specialty Pharmacy is complex and riddled with information asymmetry.  But, it just got a lot easier. CareSet provides the experience and unblocked data to connect your new medication with the Specialty Pharmacies and prescribing physicians you need to reach your target patient populations.Characterizing the industry, the co-founder and former president of […]

In specialty pharmacies, some medications may have partially blocked data. Manufacturers, payers, and specialty pharmacies can elect to block this data. When they do, it’s no longer visible to their allied and competitive healthcare stakeholders, like yourself. CareSet’s Part D Targeting product provides brand teams clarity using Medicare’s unblocked claims data. This allows us to […]

On 8/30/21, I had the honor of co-chairing the first roundtable from NCPDP’s (National Council for Prescription Drug Programs) PharmTechnology Innovation (PTI) Accelerator.  Our presenters discussed the different elements related to value-based agreements (VBA). Our incredible speakers included: John W. Hill, MBAHCM, CNED, Executive Vice President & GM with the National Council for Prescription Drug […]

CareSet is proud to announce that we are now the FIRST (that we know of) company with access to fee-for-service claims data (Part A, B & D), refreshed monthly, and with an industry best 2-week lag. CareSet is using this data to perform analysis of the ongoing COVID pandemic, and how it impacts Medicare patients […]

While pharma marketers continue to navigate their brand through COVID-19, non-personal promotion appears to be the best approach for the time being. In order to reach optimal efficiency, marketers will want to utilize the best list of providers for their brand. Publicly available datasets, as well as commercially available datasets, are all over the internet. […]